Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Intuitive Surgical (ISRG) stock may be a solid investment at this time. Why? Because you're getting high margins – indicative of pricing power and cash generation capability – for a discounted price.
ISRG leverages refurbished Xi systems to reach cost-sensitive markets and expand access beyond hospitals.
Intuitive Surgical's robotics surge and Medtronic's broad innovation push set the stage for a high-tech showdown in next-gen minimally invasive care.
Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock?
After reaching an important support level, Intuitive Surgical, Inc. (ISRG) could be a good stock pick from a technical perspective. ISRG surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
Intuitive Surgical's Ion platform represents robust growth potential with strong procedure growth. Clinical trial data demonstrate superiority in diagnostic yield.
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical is a pioneer in the field of surgical robotics. The company's da Vinci system is a leading technology platform in its segment.
As the overall market trend weakens, one area that remains intact is medical stocks — namely Intuitive Surgical.
Intuitive Surgical's new force-feedback upgrades for da Vinci 5 could spark its next adoption wave as early clinical evidence strengthens.
Intuitive Surgical's shares soar over 28% in a month on da Vinci 5 momentum, but margin and valuation pressures suggest caution for new buyers.